[Federal Register Volume 65, Number 177 (Tuesday, September 12, 2000)]
[Notices]
[Pages 55031-55032]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-23316]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the Cancer 
Advisory Panel for Complementary and Alternative Medicine (CAPCAM).
    The meeting is open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the

[[Page 55032]]

Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, for the discussions of individual patient 
information, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Cancer Advisory Panel for Complementary and 
Alternative Medicine.
    Date: September 18, 2000.
    Open: 1:00 pm to adjournment.
    Agenda: The agenda will include a report on clinical trial data 
on Virulizen (R) use for pancreatic cancer, an update on NIH 
initiatives for CAM and Cancer treatments, and other business of the 
Panel.
    Closed: 8:30 am to 11:30 am.
    Agenda: To discuss individual patient information.
    Place: Pooks Hill Marriott, 5151 Pooks Hill Road, Bethesda, MD.
    Contact Person: Richard Nahin, Ph.D., Executive Secretary, 
National Center for Complementary & Alternative Medicine, National 
Institutes of Health, 9000 Rockville Pike, Room 5B36, Bethesda, MD 
20892, 301-496-4792.

    The public comments session is scheduled from 4:30 pm to 5:00 pm. 
Each speaker will be permitted 5 minutes for their presentation. 
Interested individuals and representatives of organizations are 
requested to notify Dr. Richard Nahin, National Center for 
Complementary and Alternative Medicine, NIH, 31 Center Drive, (MSC 
2182), Building 31, Room 5B36, Bethesda, Maryland, 20892, 301-496-4792, 
Fax 301-402-4741. Letters of intent to present comments, along with a 
brief description of the organization represented, should be received 
no later than 5:00 pm on September 13, 2000. Only one representative of 
an organization may present oral comments. Any person attending the 
meeting who does not request an opportunity to speak in advance of the 
meeting may be considered for oral presentation, if time permits. and 
at the discretion of the Chairperson. In addition, written comments may 
be submitted to Dr. Nahin at the address listed above up to ten 
calendar days (September 28, 2000) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by Dr. Richard Nahin, Executive Secretary, 
CAPCAM, National Institutes of Health, Building 31, Room 5B36, 31 
Center Drive, Bethesda, Maryland 20892, 301 496-4792, Fax 301-402-4741.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Dated: September 1, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 00-23316 Filed 9-11-00; 8:45 am]
BILLING CODE 4140-01-M